175 related articles for article (PubMed ID: 36374935)
1. Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.
Qi L; Chen Y
J Clin Endocrinol Metab; 2023 Jan; 108(2):251-270. PubMed ID: 36374935
[TBL] [Abstract][Full Text] [Related]
2. Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus.
Jung Y; Koo BK; Jang SY; Kim D; Lee H; Lee DH; Joo SK; Jung YJ; Park JH; Yoo T; Choi M; Lee MK; Kang SW; Chang MS; Kim W; Hwang GS;
Liver Int; 2021 Dec; 41(12):2892-2902. PubMed ID: 34358397
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
[TBL] [Abstract][Full Text] [Related]
4. Circulating Bile Acid Profiles: A Need for Further Examination.
Qi L; Tian Y; Chen Y
J Clin Endocrinol Metab; 2021 Oct; 106(11):3093-3112. PubMed ID: 34279029
[TBL] [Abstract][Full Text] [Related]
5. Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status.
Lee SG; Lee YH; Choi E; Cho Y; Kim JH
Clin Chem Lab Med; 2019 Jul; 57(8):1218-1228. PubMed ID: 30964746
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
7. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
[TBL] [Abstract][Full Text] [Related]
8. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
Nimer N; Choucair I; Wang Z; Nemet I; Li L; Gukasyan J; Weeks TL; Alkhouri N; Zein N; Tang WHW; Fischbach MA; Brown JM; Allayee H; Dasarathy S; Gogonea V; Hazen SL
Metabolism; 2021 Mar; 116():154457. PubMed ID: 33275980
[TBL] [Abstract][Full Text] [Related]
9. The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids.
Gottlieb A; Bechmann L; Canbay A
Ann Hepatol; 2018; 17(3):340-341. PubMed ID: 29735794
[TBL] [Abstract][Full Text] [Related]
10. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
Puri P; Daita K; Joyce A; Mirshahi F; Santhekadur PK; Cazanave S; Luketic VA; Siddiqui MS; Boyett S; Min HK; Kumar DP; Kohli R; Zhou H; Hylemon PB; Contos MJ; Idowu M; Sanyal AJ
Hepatology; 2018 Feb; 67(2):534-548. PubMed ID: 28696585
[TBL] [Abstract][Full Text] [Related]
11. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
Chávez-Talavera O; Haas J; Grzych G; Tailleux A; Staels B
Curr Opin Lipidol; 2019 Jun; 30(3):244-254. PubMed ID: 30893108
[TBL] [Abstract][Full Text] [Related]
12. Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
Liu AN; Xu CF; Liu YR; Sun DQ; Jiang L; Tang LJ; Zhu PW; Chen SD; Liu WY; Wang XD; Targher G; Byrne CD; Wong VW; Fu J; Su MM; Loomba R; Zheng MH; Ni Y
Aliment Pharmacol Ther; 2023 Apr; 57(8):872-885. PubMed ID: 36670060
[TBL] [Abstract][Full Text] [Related]
13. The Potential of Bile Acids as Biomarkers for Metabolic Disorders.
Yin C; Zhong R; Zhang W; Liu L; Chen L; Zhang H
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569498
[TBL] [Abstract][Full Text] [Related]
14. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
Chávez-Talavera O; Wargny M; Pichelin M; Descat A; Vallez E; Kouach M; Bigot-Corbel E; Joliveau M; Goossens JF; Le May C; Hadjadj S; Hanf R; Tailleux A; Staels B; Cariou B
Metabolism; 2020 Feb; 103():154042. PubMed ID: 31785259
[TBL] [Abstract][Full Text] [Related]
15. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.
Legry V; Francque S; Haas JT; Verrijken A; Caron S; Chávez-Talavera O; Vallez E; Vonghia L; Dirinck E; Verhaegen A; Kouach M; Lestavel S; Lefebvre P; Van Gaal L; Tailleux A; Paumelle R; Staels B
J Clin Endocrinol Metab; 2017 Oct; 102(10):3783-3794. PubMed ID: 28938455
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.
Reeves HL; Zaki MY; Day CP
Dig Dis Sci; 2016 May; 61(5):1234-45. PubMed ID: 26921078
[TBL] [Abstract][Full Text] [Related]
17. NASH-related increases in plasma bile acid levels depend on insulin resistance.
Grzych G; Chávez-Talavera O; Descat A; Thuillier D; Verrijken A; Kouach M; Legry V; Verkindt H; Raverdy V; Legendre B; Caiazzo R; Van Gaal L; Goossens JF; Paumelle R; Francque S; Pattou F; Haas JT; Tailleux A; Staels B
JHEP Rep; 2021 Apr; 3(2):100222. PubMed ID: 33615207
[TBL] [Abstract][Full Text] [Related]
18. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
[TBL] [Abstract][Full Text] [Related]
19. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
Kobayashi Y; Hara N; Sugimoto R; Mifuji-Moroka R; Tanaka H; Eguchi A; Iwasa M; Hasegawa H; Iwata K; Takei Y; Taguchi O
Intern Med; 2017; 56(7):755-762. PubMed ID: 28381740
[TBL] [Abstract][Full Text] [Related]
20. Bile Acid Alterations Characterize the Early Onset and Progression of Nonalcoholic Fatty Liver Disease in Young Mice Fed with High Fat and Fructose Diet.
Xiang W; Liu A; Xu C; Zhang D; Li W; Ni Y
Mol Nutr Food Res; 2023 Jun; 67(11):e2200636. PubMed ID: 36938649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
